Explore detailed financial insights for NSE: Ambuja Cements Limited, including share price, quarterly results, governance, and stock forecasts for 2025.

NSE: Ambuja Cements Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept

Stay informed with the latest announcements for Ambujacem, including updates on board meetings and corporate actions.

AMBUJACEM
Ambuja Cements Limited - https://www.ambujacement.com
Ambuja Cements Limited, together with its subsidiaries, manufactures and markets cement and cement related products to individual homebuilders, masons and contractors, and architects and engineers in India. The company offers Portland pozzolana cement and ordinary Portland cement, as well as temperature resistant concrete blocks, Blaine Portland cement, and micro materials. It sells its products through dealers, authorized retail stockiest, retailers, and authorized sales representatives. The company was formerly known as Gujarat Ambuja Cements Limited and changed its name to Ambuja Cements Limited in April 2007. The company was incorporated in 1981 and is based in Ahmedabad, India. Ambuja Cements Limited operates as a subsidiary of Holderind Investments Ltd.

Ambuja Cements Limited Share Price Today

528.30
OPEN
528.30
HIGH
497.10
LOW
509.55
CLOSE
9,999 K
VOLUME
136,199 Cr
Market Cap
3637400
Average Volume
Basic Materials
Sector
NSI
Exchange

Ambuja Cements Limited Share Analysis & 2025 Insights

// -->

Investor Presentations

Date Description Download
SIP
Lumpsum
₹25,000
12%
10 Yr

Invested Amount: ₹

Estimated Returns: ₹

Total Value: ₹

NSE: AMBUJACEM Stock Actions

Company
Symbol
ISIN
Subject
Ex Date
Face Value
Broadcast Date
Ambuja Cements Limited
AMBUJACEM
INE079A01024
Dividend - Rs 2 Per Share
14 Jun 2024
2
N/A
Ambuja Cements Limited
AMBUJACEM
INE079A01024
Dividend - Rs 2.50 Per Share
07 Jul 2023
2
N/A
Ambuja Cements Limited
AMBUJACEM
INE079A01024
Dividend - Rs 6.30 Per Share
30 Mar 2022
2
N/A
Ambuja Cements Limited
AMBUJACEM
INE079A01024
Dividend - Re 1 Per Share
19 Mar 2021
2
N/A
Ambuja Cements Limited
AMBUJACEM
INE079A01024
Interim Dividend-Rs 17 Per Share
05 Nov 2020
2
N/A

NSE: AMBUJACEM Recent Announcements

Symbol
Date
Description
Industry
AMBUJACEM
01 Jan 2025, 23:50:02
Amalgamation/Merger
Cement And Cement Products
AMBUJACEM
31 Dec 2024, 21:25:16
Updates
Cement And Cement Products
AMBUJACEM
30 Dec 2024, 15:21:02
Trading Window-XBRL
Cement And Cement Products
AMBUJACEM
30 Dec 2024, 15:18:37
Trading Window
Cement And Cement Products
AMBUJACEM
18 Dec 2024, 16:46:02
Amalgamation OR Merger-XBRL
Cement And Cement Products

NSE: AMBUJACEM Corporate Governance

Name
Symbol
Timestamp
Submission Date
XBRL Document
Ambuja Cements Limited
AMBUJACEM
18 Oct 2024, 19:50:00
18 Oct 2024, 19:50:00
Ambuja Cements Limited
AMBUJACEM
18 Jul 2024, 16:32:00
18 Jul 2024, 16:32:00
Ambuja Cements Limited
AMBUJACEM
20 Apr 2024, 17:14:00
20 Apr 2024, 17:30:00
Ambuja Cements Limited
AMBUJACEM
06 Feb 2024, 18:00:00
06 Feb 2024, 18:30:00
Ambuja Cements Limited
AMBUJACEM
23 Nov 2023, 15:45:00
23 Nov 2023, 16:15:00

NSE: AMBUJACEM Detailed Governance

Category
Date of Birth
Date of Initial Appointment
DIN
Director Name
Status
Chairperson Related To Promoters,Non-Executive Director
24 Jun 1962
16 Sep 2022
00006273
Gautam S. Adani
Active
Non-Executive Director
07 Apr 1987
16 Sep 2022
03088095
Karan Adani
Active
Independent Director
10 Jan 1954
16 Sep 2022
00034051
Maheswar Sahu
Active
Independent Director
14 Jan 1958
16 Sep 2022
05328267
Rajnish Kumar
Active
Independent Director
04 Oct 1963
16 Sep 2022
00007116
Ameet Desai
Active

NSE: AMBUJACEM Board Meetings

Purpose
Symbol
Industry
ISIN
Name
Time
Ambuja Cements Limited has informed the Exchange about Board Meeting to be held on 28-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 .
AMBUJACEM
N/A
INE079A01024
Ambuja Cements Limited
15 Oct 2024, 18:08:53
Financial Results
AMBUJACEM
N/A
INE079A01024
Ambuja Cements Limited
16 Jul 2024, 15:51:24
AMBUJA CEMENTS LIMITED has informed the Exchange about Board Meeting to be held on 01-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend.
AMBUJACEM
N/A
INE079A01024
Ambuja Cements Limited
19 Apr 2024, 17:11:02
AMBUJA CEMENTS LIMITED has informed the Exchange about Board Meeting to be held on 31-Jan-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 .
AMBUJACEM
N/A
INE079A01024
Ambuja Cements Limited
17 Jan 2024, 20:35:02
Financial Results
AMBUJACEM
N/A
INE079A01024
Ambuja Cements Limited
23 Oct 2023, 16:21:02

NSE: AMBUJACEM Event Calendar

Purpose
Symbol
Industry
ISIN
Name
Time
Description
Financial Results
AMBUJACEM
-
INE079A01024
Ambuja Cements Limited
15 Oct 2024, 00:00:00
To consider and approve the financial results for the period ended September 30, 2024
Financial Results
AMBUJACEM
-
INE079A01024
Ambuja Cements Limited
16 Jul 2024, 00:00:00
To consider and approve the Unaudited financial results for the period ended Jun 30, 2024
Financial Results/Dividend
AMBUJACEM
-
INE079A01024
Ambuja Cements Limited
19 Apr 2024, 00:00:00
To consider and approve the financial results for the period ended March 31, 2024 and to recommend dividend, if any on equity shares of the Company, for the financial year 2023-24
Financial Results
AMBUJACEM
-
INE079A01024
Ambuja Cements Limited
17 Jan 2024, 00:00:00
Unaudited Standalone and Consolidated Financial results for the period ended December 31, 2023.
Financial Results
AMBUJACEM
-
INE079A01024
Ambuja Cements Limited
23 Oct 2023, 00:00:00
To consider and approve the Unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2023.

NSE: AMBUJACEM Balance Sheet Data In (Cr)

date period_type Ordinary Shares Number Share Issued Total Debt Tangible Book Value Invested Capital Working Capital Net Tangible Assets Capital Lease Obligations Common Stock Equity Total Capitalization Total Equity Gross Minority Interest Minority Interest Stockholders Equity Other Equity Interest Retained Earnings Additional Paid In Capital Capital Stock Common Stock Total Liabilities Net Minority Interest Total Non Current Liabilities Net Minority Interest Other Non Current Liabilities Non Current Deferred Taxes Liabilities Long Term Debt And Capital Lease Obligation Long Term Capital Lease Obligation Long Term Debt Long Term Provisions Current Liabilities Other Current Liabilities Current Debt And Capital Lease Obligation Current Capital Lease Obligation Current Debt Pensionand Other Post Retirement Benefit Plans Current Current Provisions Payables Other Payable Dividends Payable Total Tax Payable Accounts Payable Total Assets Total Non Current Assets Other Non Current Assets Non Current Prepaid Assets Non Current Deferred Taxes Assets Investmentin Financial Assets Held To Maturity Securities Available For Sale Securities Financial Assets Designatedas Fair Value Through Profitor Loss Long Term Equity Investment Investmentsin Joint Venturesat Cost Investmentsin Associatesat Cost Goodwill And Other Intangible Assets Other Intangible Assets Goodwill Net PPE Accumulated Depreciation Gross PPE Construction In Progress Other Properties Machinery Furniture Equipment Buildings And Improvements Land And Improvements Properties Current Assets Other Current Assets Assets Held For Sale Current Restricted Cash Prepaid Assets Inventory Other Inventories Finished Goods Work In Process Raw Materials Other Receivables Taxes Receivable Accounts Receivable Allowance For Doubtful Accounts Receivable Gross Accounts Receivable Cash Cash Equivalents And Short Term Investments Other Short Term Investments Cash And Cash Equivalents Cash Equivalents Cash Financial
2024-09-30T00:00:00 quarterly 2,463,123,478.00 2,463,123,478.00 7,792,400,000.00 336,187,700,000.00 504,161,700,000.00 92,577,400,000.00 336,187,700,000.00 7,387,200,000.00 503,756,500,000.00 504,049,600,000.00 599,159,300,000.00 95,402,800,000.00 503,756,500,000.00 498,830,300,000.00 0.00 0.00 4,926,200,000.00 4,926,200,000.00 166,560,400,000.00 33,461,300,000.00 0.00 23,904,700,000.00 5,829,300,000.00 5,536,200,000.00 293,100,000.00 2,940,900,000.00 133,099,100,000.00 34,455,100,000.00 1,963,100,000.00 1,851,000,000.00 112,100,000.00 0.00 428,700,000.00 63,432,800,000.00 0.00 0.00 28,918,300,000.00 34,514,500,000.00 765,719,700,000.00 540,043,200,000.00 36,034,100,000.00 0.00 1,773,500,000.00 15,435,300,000.00 0.00 15,435,300,000.00 0.00 570,700,000.00 0.00 0.00 167,568,800,000.00 59,008,100,000.00 108,560,700,000.00 305,722,000,000.00 0.00 305,722,000,000.00 64,716,100,000.00 241,005,900,000.00 0.00 0.00 0.00 0.00 225,676,500,000.00 48,007,900,000.00 0.00 0.00 0.00 41,716,600,000.00 0.00 0.00 0.00 0.00 79,900,000.00 0.00 18,894,900,000.00 0.00 0.00 116,977,200,000.00 94,286,700,000.00 22,690,500,000.00 0.00 0.00
2024-03-31T00:00:00 annual 2,197,675,987.00 2,197,675,987.00 6,990,100,000.00 297,816,000,000.00 414,918,400,000.00 127,013,500,000.00 297,816,000,000.00 6,622,300,000.00 414,550,600,000.00 414,739,700,000.00 508,459,000,000.00 93,908,400,000.00 414,550,600,000.00 27,923,500,000.00 109,177,100,000.00 213,200,200,000.00 4,395,400,000.00 4,395,400,000.00 144,519,100,000.00 23,230,300,000.00 0.00 15,491,000,000.00 5,179,600,000.00 4,990,500,000.00 189,100,000.00 2,559,700,000.00 121,288,800,000.00 9,608,200,000.00 1,810,500,000.00 1,631,800,000.00 178,700,000.00 429,700,000.00 429,700,000.00 90,969,900,000.00 32,864,200,000.00 468,800,000.00 26,549,400,000.00 31,087,500,000.00 652,978,100,000.00 404,675,800,000.00 28,426,000,000.00 3,191,400,000.00 369,400,000.00 745,800,000.00 0.00 506,800,000.00 239,000,000.00 622,600,000.00 0.00 0.00 116,734,600,000.00 34,541,900,000.00 82,192,700,000.00 233,734,600,000.00 -98,410,900,000.00 332,145,500,000.00 26,584,500,000.00 4,475,800,000.00 226,502,300,000.00 46,768,400,000.00 27,814,500,000.00 0.00 248,302,300,000.00 703,400,000.00 219,300,000.00 11,137,900,000.00 23,939,900,000.00 36,085,500,000.00 15,677,100,000.00 2,918,000,000.00 7,987,800,000.00 9,502,600,000.00 15,230,500,000.00 0.00 12,131,400,000.00 -851,000,000.00 12,982,400,000.00 149,073,700,000.00 119,002,700,000.00 30,071,000,000.00 23,669,200,000.00 6,401,800,000.00
2024-03-31T00:00:00 quarterly 2,197,675,987.00 2,197,675,987.00 6,990,100,000.00 297,816,000,000.00 414,918,400,000.00 127,013,500,000.00 297,816,000,000.00 6,622,300,000.00 414,550,600,000.00 414,739,700,000.00 508,459,000,000.00 93,908,400,000.00 414,550,600,000.00 27,923,500,000.00 109,177,100,000.00 213,200,200,000.00 4,395,400,000.00 4,395,400,000.00 144,519,100,000.00 23,230,300,000.00 0.00 15,491,000,000.00 5,179,600,000.00 4,990,500,000.00 189,100,000.00 2,559,700,000.00 121,288,800,000.00 9,608,200,000.00 1,810,500,000.00 1,631,800,000.00 178,700,000.00 429,700,000.00 429,700,000.00 90,969,900,000.00 32,864,200,000.00 468,800,000.00 26,549,400,000.00 31,087,500,000.00 652,978,100,000.00 404,675,800,000.00 28,426,000,000.00 3,191,400,000.00 369,400,000.00 745,800,000.00 0.00 506,800,000.00 239,000,000.00 622,600,000.00 0.00 0.00 116,734,600,000.00 34,541,900,000.00 82,192,700,000.00 233,734,600,000.00 -98,410,900,000.00 332,145,500,000.00 26,584,500,000.00 4,475,800,000.00 226,502,300,000.00 46,768,400,000.00 27,814,500,000.00 0.00 248,302,300,000.00 703,400,000.00 219,300,000.00 11,137,900,000.00 23,939,900,000.00 36,085,500,000.00 15,677,100,000.00 2,918,000,000.00 7,987,800,000.00 9,502,600,000.00 15,230,500,000.00 0.00 12,131,400,000.00 -851,000,000.00 12,982,400,000.00 149,073,700,000.00 119,002,700,000.00 30,071,000,000.00 23,669,200,000.00 6,401,800,000.00
2023-09-30T00:00:00 quarterly 1,985,645,229.00 1,985,645,229.00 7,451,700,000.00 246,601,500,000.00 329,510,200,000.00 94,412,800,000.00 246,601,500,000.00 7,009,900,000.00 329,068,400,000.00 329,323,900,000.00 403,040,000,000.00 73,971,600,000.00 329,068,400,000.00 325,097,100,000.00 0.00 0.00 3,971,300,000.00 3,971,300,000.00 130,764,500,000.00 15,983,500,000.00 464,700,000.00 7,455,500,000.00 5,371,800,000.00 5,116,300,000.00 255,500,000.00 2,691,500,000.00 114,781,000,000.00 41,272,600,000.00 2,079,900,000.00 1,893,600,000.00 186,300,000.00 164,300,000.00 164,300,000.00 49,349,200,000.00 0.00 0.00 24,640,400,000.00 24,708,800,000.00 533,804,500,000.00 324,610,700,000.00 21,584,800,000.00 0.00 0.00 16,180,800,000.00 0.00 16,180,800,000.00 0.00 1,693,900,000.00 0.00 0.00 82,466,900,000.00 3,770,000,000.00 78,696,900,000.00 188,498,900,000.00 0.00 188,498,900,000.00 21,836,100,000.00 166,662,800,000.00 0.00 0.00 0.00 0.00 209,193,800,000.00 21,804,700,000.00 21,000,000.00 0.00 0.00 36,000,300,000.00 0.00 0.00 0.00 0.00 68,000,000.00 4,114,200,000.00 17,464,400,000.00 0.00 0.00 129,721,200,000.00 118,356,100,000.00 11,365,100,000.00 0.00 0.00
2021-12-31T00:00:00 annual 1,985,645,229.00 1,985,645,229.00 4,765,700,000.00 172,599,400,000.00 254,006,800,000.00 57,932,200,000.00 172,599,400,000.00 4,296,300,000.00 253,537,400,000.00 253,972,400,000.00 324,987,700,000.00 71,450,300,000.00 253,537,400,000.00 141,200,000.00 65,162,000,000.00 124,810,900,000.00 3,971,300,000.00 3,971,300,000.00 127,058,200,000.00 14,806,200,000.00 367,400,000.00 7,561,900,000.00 4,060,200,000.00 3,625,200,000.00 435,000,000.00 2,815,400,000.00 112,252,000,000.00 10,070,500,000.00 705,500,000.00 671,100,000.00 34,400,000.00 246,400,000.00 246,400,000.00 81,805,900,000.00 33,118,200,000.00 500,500,000.00 19,059,000,000.00 29,128,200,000.00 452,045,900,000.00 281,861,700,000.00 9,579,500,000.00 11,560,300,000.00 29,100,000.00 1,086,100,000.00 37,000,000.00 847,100,000.00 239,000,000.00 1,705,100,000.00 497,900,000.00 1,207,200,000.00 80,938,000,000.00 2,241,100,000.00 78,696,900,000.00 163,274,900,000.00 -69,512,800,000.00 232,787,700,000.00 21,677,300,000.00 924,600,000.00 151,695,500,000.00 36,332,400,000.00 22,157,900,000.00 0.00 170,184,200,000.00 232,500,000.00 254,400,000.00 3,344,900,000.00 14,664,600,000.00 27,380,400,000.00 10,465,300,000.00 2,569,100,000.00 7,847,300,000.00 6,498,700,000.00 4,346,800,000.00 0.00 6,190,700,000.00 -764,100,000.00 6,954,800,000.00 113,769,900,000.00 185,000,000.00 113,584,900,000.00 111,498,800,000.00 2,086,100,000.00
2020-12-31T00:00:00 annual 1,985,645,229.00 1,985,645,229.00 4,706,000,000.00 146,608,600,000.00 228,012,000,000.00 35,444,300,000.00 146,608,600,000.00 4,270,000,000.00 227,576,000,000.00 228,012,000,000.00 290,984,900,000.00 63,408,900,000.00 227,576,000,000.00 82,000,000.00 39,259,800,000.00 124,810,900,000.00 3,971,300,000.00 3,971,300,000.00 106,222,100,000.00 13,618,100,000.00 400,500,000.00 6,260,000,000.00 4,242,200,000.00 3,806,200,000.00 436,000,000.00 2,714,100,000.00 92,604,000,000.00 9,194,300,000.00 463,800,000.00 463,800,000.00 0.00 211,400,000.00 211,400,000.00 65,117,500,000.00 29,191,700,000.00 582,800,000.00 13,208,900,000.00 22,134,100,000.00 397,207,000,000.00 269,157,900,000.00 -461,000,000.00 13,218,200,000.00 29,100,000.00 1,000,100,000.00 37,000,000.00 910,100,000.00 90,000,000.00 1,546,000,000.00 430,200,000.00 1,115,800,000.00 80,967,400,000.00 2,206,300,000.00 78,761,100,000.00 148,110,000,000.00 -58,828,100,000.00 206,938,100,000.00 24,218,500,000.00 769,000,000.00 127,423,200,000.00 33,527,000,000.00 21,000,400,000.00 0.00 128,048,300,000.00 375,100,000.00 261,300,000.00 3,178,300,000.00 11,693,900,000.00 16,485,800,000.00 4,663,700,000.00 1,999,500,000.00 3,517,600,000.00 6,305,000,000.00 3,541,200,000.00 712,600,000.00 5,611,300,000.00 -914,000,000.00 6,525,300,000.00 86,188,800,000.00 473,200,000.00 85,715,600,000.00 83,984,300,000.00 1,731,300,000.00
2019-12-31T00:00:00 annual 1,985,645,229.00 1,985,645,229.00 410,600,000.00 159,826,400,000.00 241,190,500,000.00 52,487,000,000.00 159,826,400,000.00 0.00 240,779,900,000.00 241,132,700,000.00 298,147,500,000.00 57,367,600,000.00 240,779,900,000.00 58,700,000.00 52,487,000,000.00 124,810,900,000.00 3,971,300,000.00 3,971,300,000.00 103,675,900,000.00 12,972,800,000.00 358,300,000.00 9,367,300,000.00 352,800,000.00 0.00 352,800,000.00 2,888,200,000.00 90,703,100,000.00 9,132,100,000.00 57,800,000.00 0.00 57,800,000.00 1,098,900,000.00 1,098,900,000.00 63,893,300,000.00 27,553,900,000.00 518,700,000.00 12,491,900,000.00 23,328,800,000.00 401,823,400,000.00 258,633,300,000.00 -527,100,000.00 9,938,800,000.00 41,600,000.00 621,200,000.00 37,000,000.00 621,200,000.00 0.00 1,458,700,000.00 428,900,000.00 1,029,800,000.00 80,953,500,000.00 2,138,600,000.00 78,814,900,000.00 141,604,200,000.00 -46,387,700,000.00 187,991,900,000.00 15,544,300,000.00 243,700,000.00 120,419,400,000.00 32,806,200,000.00 18,978,300,000.00 0.00 143,190,100,000.00 477,600,000.00 352,500,000.00 570,800,000.00 12,109,700,000.00 20,965,000,000.00 5,896,400,000.00 3,450,800,000.00 4,520,500,000.00 7,097,300,000.00 4,874,200,000.00 0.00 10,685,600,000.00 -514,400,000.00 11,200,000,000.00 93,154,700,000.00 3,035,900,000.00 90,118,800,000.00 89,143,100,000.00 975,700,000.00

NSE: AMBUJACEM Cash Flow Data In (Cr)

date period_type Free Cash Flow Repayment Of Debt Issuance Of Debt Issuance Of Capital Stock Capital Expenditure End Cash Position Other Cash Adjustment Outside Changein Cash Beginning Cash Position Changes In Cash Financing Cash Flow Net Other Financing Charges Interest Paid Cff Cash Dividends Paid Common Stock Dividend Paid Net Common Stock Issuance Common Stock Issuance Net Issuance Payments Of Debt Net Short Term Debt Issuance Short Term Debt Payments Net Long Term Debt Issuance Long Term Debt Payments Long Term Debt Issuance Investing Cash Flow Net Other Investing Changes Interest Received Cfi Dividends Received Cfi Net Investment Purchase And Sale Sale Of Investment Purchase Of Investment Net Business Purchase And Sale Sale Of Business Purchase Of Business Net PPE Purchase And Sale Sale Of PPE Purchase Of PPE Capital Expenditure Reported Operating Cash Flow Taxes Refund Paid Change In Working Capital Change In Other Current Liabilities Change In Other Current Assets Change In Payable Change In Inventory Change In Receivables Other Non Cash Items Stock Based Compensation Provisionand Write Offof Assets Depreciation And Amortization Depreciation Gain Loss On Investment Securities Net Foreign Currency Exchange Gain Loss Gain Loss On Sale Of PPE Gain Loss On Sale Of Business Net Income From Continuing Operations
2024-03-31T00:00:00 annual 11,633,600,000.00 -240,500,000.00 0.00 66,609,600,000.00 -44,824,600,000.00 30,071,000,000.00 94,000,000.00 6,135,400,000.00 23,841,600,000.00 56,887,700,000.00 0.00 -2,340,800,000.00 -4,964,100,000.00 0.00 66,609,600,000.00 66,609,600,000.00 -240,500,000.00 0.00 0.00 -240,500,000.00 -240,500,000.00 0.00 -89,504,300,000.00 0.00 10,036,000,000.00 260,400,000.00 -16,251,000,000.00 534,700,000.00 -16,785,700,000.00 -23,082,200,000.00 460,500,000.00 -23,542,700,000.00 -39,611,400,000.00 5,213,200,000.00 -44,824,600,000.00 0.00 56,458,200,000.00 -9,155,600,000.00 1,940,900,000.00 -7,260,200,000.00 9,752,400,000.00 1,029,800,000.00 -2,282,900,000.00 243,500,000.00 -8,656,000,000.00 0.00 -1,160,600,000.00 16,233,800,000.00 16,233,800,000.00 -576,100,000.00 24,700,000.00 -1,158,100,000.00 0.00 59,006,200,000.00
2021-12-31T00:00:00 annual 29,750,600,000.00 0.00 0.00 0.00 -23,341,000,000.00 113,584,900,000.00 5,800,000.00 85,715,600,000.00 27,863,500,000.00 -5,157,600,000.00 35,400,000.00 -1,318,000,000.00 -2,021,000,000.00 -2,021,000,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -20,070,500,000.00 -200,000.00 2,783,100,000.00 43,100,000.00 66,900,000.00 215,900,000.00 -149,000,000.00 0.00 0.00 0.00 -22,963,400,000.00 377,600,000.00 -23,341,000,000.00 0.00 53,091,600,000.00 -6,476,100,000.00 -3,314,100,000.00 3,960,700,000.00 -1,860,400,000.00 6,503,800,000.00 -11,217,100,000.00 -819,900,000.00 -1,548,700,000.00 80,100,000.00 1,243,000,000.00 11,524,900,000.00 11,524,900,000.00 -122,500,000.00 33,600,000.00 252,700,000.00 0.00 51,644,700,000.00
2020-12-31T00:00:00 annual 30,986,600,000.00 -58,600,000.00 84,700,000.00 0.00 -17,336,500,000.00 85,715,600,000.00 8,400,000.00 90,118,800,000.00 -4,411,600,000.00 -39,562,200,000.00 -88,400,000.00 -1,130,100,000.00 -36,646,100,000.00 -36,646,100,000.00 0.00 0.00 26,100,000.00 -58,600,000.00 -58,600,000.00 84,700,000.00 -58,600,000.00 84,700,000.00 -13,172,500,000.00 -200,000.00 3,910,400,000.00 27,900,000.00 -79,800,000.00 162,207,200,000.00 -162,287,000,000.00 222,400,000.00 222,400,000.00 0.00 -17,253,200,000.00 83,300,000.00 -17,336,500,000.00 -17,336,500,000.00 48,323,100,000.00 -11,701,700,000.00 7,572,300,000.00 0.00 0.00 922,400,000.00 4,204,900,000.00 2,445,000,000.00 -966,800,000.00 36,600,000.00 135,300,000.00 11,617,800,000.00 11,617,800,000.00 -258,200,000.00 82,900,000.00 328,600,000.00 -129,100,000.00 39,915,900,000.00
2019-12-31T00:00:00 annual 30,712,700,000.00 0.00 0.00 0.00 -16,674,300,000.00 90,118,800,000.00 23,200,000.00 60,931,100,000.00 29,164,500,000.00 -6,293,700,000.00 -871,600,000.00 -1,130,400,000.00 -2,978,500,000.00 -2,978,500,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -11,928,800,000.00 1,200,000.00 3,922,900,000.00 33,500,000.00 184,000,000.00 74,363,100,000.00 -74,179,100,000.00 0.00 0.00 0.00 -16,070,400,000.00 603,900,000.00 -16,674,300,000.00 -16,674,300,000.00 47,387,000,000.00 -5,298,700,000.00 6,511,500,000.00 0.00 0.00 632,400,000.00 8,398,500,000.00 -2,519,400,000.00 -3,583,700,000.00 11,600,000.00 -32,900,000.00 11,525,200,000.00 11,525,200,000.00 -525,200,000.00 3,300,000.00 -169,200,000.00 0.00 38,753,100,000.00

NSE: AMBUJACEM Income Statement Data In (Cr)

date period_type Tax Effect Of Unusual Items Tax Rate For Calcs Normalized EBITDA Total Unusual Items Total Unusual Items Excluding Goodwill Net Income From Continuing Operation Net Minority Interest Reconciled Depreciation Reconciled Cost Of Revenue EBITDA EBIT Net Interest Income Interest Expense Interest Income Normalized Income Net Income From Continuing And Discontinued Operation Total Expenses Rent Expense Supplemental Diluted Average Shares Basic Average Shares Diluted EPS Basic EPS Diluted NI Availto Com Stockholders Net Income Common Stockholders Otherunder Preferred Stock Dividend Net Income Minority Interests Net Income Including Noncontrolling Interests Net Income Continuous Operations Tax Provision Pretax Income Other Non Operating Income Expenses Special Income Charges Other Special Charges Write Off Restructuring And Mergern Acquisition Net Non Operating Interest Income Expense Total Other Finance Cost Interest Expense Non Operating Interest Income Non Operating Operating Income Operating Expense Other Operating Expenses Depreciation And Amortization In Income Statement Amortization Depreciation Income Statement Selling General And Administration Selling And Marketing Expense General And Administrative Expense Rent And Landing Fees Gross Profit Cost Of Revenue Total Revenue Operating Revenue
2024-03-31T00:00:00 annual 73.02 0.00 7,431.23 369.15 369.15 3,576.79 1,623.38 7,071.79 7,800.38 6,177.00 696.79 276.38 973.17 3,280.66 3,576.79 27,723.49 118.00 214.57 198.80 0.00 0.00 3,576.79 3,576.79 0.00 3,576.79 -1,161.22 4,738.01 4,738.01 1,162.61 5,900.62 14.47 306.08 -101.97 21.18 -225.29 696.79 0.00 276.38 973.17 4,806.30 20,651.70 9,759.52 1,623.38 58.21 1,565.17 8,354.12 8,276.80 77.32 118.00 25,458.00 7,071.79 32,529.79 32,529.79
2021-12-31T00:00:00 annual -25.82 0.00 6,554.10 -91.41 -91.41 2,780.38 1,152.49 5,081.08 6,462.69 5,310.13 187.96 145.66 333.62 2,845.97 2,780.38 23,491.23 169.58 198.60 198.56 0.00 0.00 2,780.38 2,780.38 0.00 2,780.38 -930.66 3,711.04 3,711.04 1,453.43 5,164.47 0.65 -109.58 120.45 -10.87 120.45 187.96 7.00 145.66 333.62 5,056.85 18,410.15 8,571.78 1,152.56 16.50 1,136.06 7,385.93 7,308.52 77.41 169.58 23,467.00 5,081.08 28,548.08 28,548.08
2020-12-31T00:00:00 annual -38.56 0.00 5,466.91 -173.32 -173.32 2,365.44 1,161.78 4,755.41 5,293.59 4,131.81 267.11 140.22 407.33 2,500.20 2,365.44 20,201.05 136.62 198.60 198.56 0.00 0.00 2,365.44 2,365.44 0.00 2,365.44 -741.40 3,106.84 3,106.84 884.75 3,991.59 2.23 -200.44 163.10 37.34 0.00 267.11 6.03 140.22 407.33 3,892.81 15,445.64 6,573.56 1,161.78 9.40 1,152.38 6,443.73 6,392.05 51.68 136.62 19,338.45 4,755.41 24,093.86 24,093.86
2019-12-31T00:00:00 annual 8.82 0.00 5,166.56 31.14 31.14 2,095.00 1,152.52 5,693.71 5,197.70 4,045.18 358.20 169.87 528.07 2,072.68 2,095.00 23,072.46 188.68 198.60 198.56 0.00 0.00 2,095.00 2,095.00 0.00 2,095.00 -688.16 2,783.16 2,783.16 1,092.15 3,875.31 0.02 -21.51 0.00 21.51 0.00 358.20 4.35 169.87 528.07 3,466.16 17,378.75 7,649.24 1,152.52 6.72 1,145.80 7,369.16 7,325.02 44.14 188.68 20,844.91 5,693.71 26,538.62 26,538.62

FII & DII Data (In Cr)

Date FII Gross Purchase FII Gross Sales FII Net Purchase / Sales DII Gross Purchase DII Gross Sales DII Net Purchase / Sales
2025-02-03 12,505.92 16,464.29 -3,958.37 19,319.48 16,611.25 2,708.23
2025-01-30 10,513.63 15,096.58 -4,582.95 13,934.35 11,768.46 2,165.89
2025-01-29 7,644.40 10,230.83 -2,586.43 12,871.38 11,078.67 1,792.71
2025-01-27 9,488.57 14,504.03 -5,015.46 16,503.43 9,861.28 6,642.15
2025-01-24 11,230.47 13,988.96 -2,758.49 12,835.41 10,433.10 2,402.31
2025-01-23 13,316.55 18,779.07 -5,462.52 14,412.73 10,700.18 3,712.55
2025-01-22 12,936.64 16,962.89 -4,026.25 15,437.18 11,796.96 3,640.22
Quarterly Results
Profit & Loss
Piotroski F-Score
5/9
0 1 2 3 4 5 6 7 8 9

Key Metrics

EPS

13.12

P/E

42.14177

P/B

2.705083

Dividend Yield

0.36%

Market Cap

136,198.63 Cr.

Face Value

204.393

Book Value

204.393

ROE

9.05%

EBITDA Growth

5,674.41 Cr.

Debt/Equity

1.301

Short Term

Subscribe to unlock this feature

Medium Term

Subscribe to unlock this feature

Long Term

Subscribe to unlock this feature

Yearly Stock Performance Heatmap

Latest Updates

AMBUJACEM News

Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI

Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:50

AMBUJACEM News

Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends

"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:47

AMBUJACEM News

FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore

Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:37

AMBUJACEM News

Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal

The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:23

AMBUJACEM News

Apple iPhone SE 4: Price To Features, 11 Things You Need To Know

iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:12

AMBUJACEM News

Rupee Closed Weaker Against The US Dollar

The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 15:54

AMBUJACEM News

Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45

Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:09

AMBUJACEM News

War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel

The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:00

Popular Questions

How to Buy ambujacem Shares on Fincept?

You can buy Ambuja Cements Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.

What is the Market Cap of ambujacem?

The market capitalization of Ambuja Cements Limited is ₹136,199 Cr as of 05 Feb 2025.

What are the PE and PB ratios of Ambuja Cements Limited?

The PE and PB ratios of Ambuja Cements Limited are Not Available and 2.705083 respectively as of 05 Feb 2025.

What is the 52 Week High of Ambuja Cements Limited?

The 52-week high of Ambuja Cements Limited is ₹706.95 as of 05 Feb 2025.

What is the 52 Week Low of Ambuja Cements Limited?

The 52-week low of Ambuja Cements Limited is ₹453.05 as of 05 Feb 2025.

What are the earnings per share (EPS) for Ambuja Cements Limited?

The Earnings Per Share (EPS) of Ambuja Cements Limited is ₹13.12 as per the most recent quarterly results available on Fincept.

What is the ROE (Return on Equity) of Ambuja Cements Limited?

The Return on Equity (ROE) of Ambuja Cements Limited is 9.05% as per the most recent financial year data. Explore more on Fincept.

BAJEL

View Stock

NBCC

View Stock

KAMDHENU

View Stock

PNBHOUSING

View Stock

IITL

View Stock

BIOCON

View Stock

HINDCOPPER

View Stock

PDSL

View Stock

IOLCP

View Stock

BEARDSELL

View Stock

ALBERTDAVD

View Stock

NAVA

View Stock

MAXHEALTH

View Stock

KOTARISUG

View Stock